IPO: Stent graft maker Trivascular Tech. jumps on opening day

Trivascular Technologies prices its initial public offering below range at $12 per share, with the stock gaining 15% in its first day.

Trivascular Technologies (NSDQ:TRIV) shares made a good showing on their first day on the Nasdaq stock exchange, having gained 15% by about 4 p.m. EST.

TriVascular

News Well, Initial Public Offering (IPO), Stent Grafts, Wall Street Beat

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1hVUWls